[Oral treatment of acute infantile diarrhoea with sucrose/electrolyte solution (author's transl)]

Archives Francaises De Pediatrie
|February 1, 1980
PubMed

Insights

Oral rehydration therapy effectively prevents and treats dehydration in infants with acute diarrhea. This study shows a specific oral solution rapidly replaces fluid losses, avoiding the need for intravenous therapy in most cases.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Public Health

Context:

  • Acute diarrhea is a leading cause of dehydration in infants globally.
  • Parenteral therapy for dehydration carries risks and is resource-intensive.
  • Oral rehydration solutions (ORS) offer a potentially safer and more accessible alternative.

Purpose:

  • To evaluate the efficacy of a specific oral rehydration solution in managing acute diarrhea in infants.
  • To determine if this ORS can prevent or treat dehydration without parenteral intervention.

Summary:

  • A study involving 161 infants (mean age 6.8 months) assessed an ORS containing sodium 50 mEq/L, potassium 25 mEq/L, bicarbonate 2 g/L, glucose 20 g/L, and sucrose 20 g/L (osmolarity 300 mOsm/kg).
  • The solution facilitated rapid replacement of fluid losses, effectively preventing and treating dehydration.
  • Parenteral therapy remained necessary only for severe cases involving shock, acidosis, or extreme diarrhea.

Impact:

  • Demonstrates the significant value of oral rehydration therapy in pediatric acute diarrhea management.
  • Highlights the potential to reduce reliance on intravenous fluids, improving patient outcomes and healthcare efficiency.
  • Provides evidence supporting the use of this specific ORS formulation in clinical practice for non-severe cases.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...